Cold Spring Harbor, NY, United States of America

Kung-Chi Chang

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Cold Spring Harbor Laboratory, Ionis Pharmaceuticals, Inc.. Active years: 2021.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Breast Cancer Treatment by Kung-Chi Chang

Introduction

Kung-Chi Chang is a notable inventor based in Cold Spring Harbor, NY, who has made significant contributions to the field of cancer research. He holds a patent that focuses on innovative methods for treating breast cancer, showcasing his commitment to advancing medical science.

Latest Patents

Kung-Chi Chang's patent, titled "Methods of treating breast cancer," provides methods, compounds, and compositions aimed at reducing the expression of a MaTAR in an animal. This invention is particularly useful for treating, preventing, delaying, or ameliorating breast cancer in individuals in need. His work in this area highlights the potential for new therapeutic approaches in oncology.

Career Highlights

Throughout his career, Kung-Chi Chang has worked with prominent organizations such as Ionis Pharmaceuticals, Inc. and Cold Spring Harbor Laboratory. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include David L. Spector and Sarah Daniela Diermeier. Their collaborative efforts have further enriched the research environment and fostered innovation in cancer treatment.

Conclusion

Kung-Chi Chang's contributions to breast cancer treatment through his patented methods exemplify the impact of innovative research in medicine. His work continues to inspire advancements in the fight against cancer.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…